Related Experiment Video

Updated: Jun 25, 2026

Non-Invasive Endotracheal Administration of Lipopolysaccharide to Induce Acute Lung Injury in Rodents
04:10

Non-Invasive Endotracheal Administration of Lipopolysaccharide to Induce Acute Lung Injury in Rodents

Published on: December 5, 2025

Suppression of acute lung inflammation by intracellular peptide delivery of a nuclear import inhibitor

Danya Liu1, Jozef Zienkiewicz, Antonio DiGiandomenico

  • 1Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-2363, USA.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|March 5, 2009
PubMed

Insights

A novel peptide inhibitor effectively reduced lung inflammation caused by Staphylococcus aureus superantigens. This finding offers a potential new strategy for treating severe pneumonia and acute respiratory distress syndrome (ARDS).

Area of Science:

  • Immunology
  • Microbiology
  • Pharmacology

Background:

  • Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) causes severe lung infections, including necrotizing pneumonia and acute respiratory distress syndrome (ARDS).
  • Staphylococcal superantigens, like staphylococcal enterotoxin B (SEB), are key virulence factors driving MRSA-induced lung inflammation.

Purpose of the Study:

  • To investigate the therapeutic potential of a cell-penetrating peptide nuclear import inhibitor targeting nuclear factor-kappaB (NF-κB) and other stress-responsive transcription factors (SRTFs).
  • To determine the inhibitor's efficacy in attenuating SEB-induced lung inflammation and associated pathologies.

Main Methods:

  • Administration of a cell-penetrating peptide nuclear import inhibitor in a model of SEB-induced lung inflammation.
  • Assessment of cytokine and chemokine production in response to SEB exposure.
  • Evaluation of immune cell infiltration (neutrophils, monocytes/macrophages, lymphocytes) into the bronchoalveolar space.
  • Measurement of vascular injury, including vascular permeability and protein leakage.
  • Analysis of systemic inflammatory responses.

Main Results:

  • The peptide inhibitor significantly suppressed the production of a broad range of cytokines and chemokines induced by SEB.
  • Inhibitor treatment markedly reduced the trafficking of key immune cells to the lungs.
  • Vascular injury, characterized by increased permeability and protein leakage, was attenuated.
  • Systemic inflammatory cytokine and chemokine induction following SEB airway exposure was also reduced.

Conclusions:

  • Intracellular delivery of this nuclear import inhibitory peptide effectively suppresses both respiratory and systemic inflammatory mediators.
  • This approach holds promise for mitigating lung inflammation and injury caused by Staphylococcus aureus superantigens, offering a potential therapeutic strategy for CA-MRSA infections.

More Related Videos

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

Intubation-mediated Intratracheal (IMIT) Instillation: A Noninvasive, Lung-specific Delivery System08:00

Intubation-mediated Intratracheal (IMIT) Instillation: A Noninvasive, Lung-specific Delivery System

Published on: November 17, 2014

Related Concept Videos

Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...